Skip to main content
. 2021 Feb 10;11(2):116. doi: 10.3390/jpm11020116

Table 2.

Development of COVID-19 before and after PSM.

Variable Development of COVID-19 Logistic Regression Analysis p-Value
OR (95% CI)
Before PSM
Control group 6471/101,697 (6.4) 1
Statin user 1309/22,633 (5.8) 0.90 (0.85, 0.96) 0.0011
After PSM
Control group 1395/17,156 (8.1) 1
Statin user 938/17,156 (5.5) 0.65 (0.60 0.71) <0.001

Presented as a number with percentage. PSM, propensity score matching; OR, odds ratio; CI, confidence interval.